Contrast Media

Contrast media, also called contrast agents, are used to enhance the blood and perfusion in tissues.This includes iodine based contrast for on computed tomography (CT), gadolinium based agents for MRI and lipid bubble contrast agents used in ultrasound.

PRAC, European Medicines Agency, gadolinium-based contrast agents, safety recommendations, brain MRI
News | Contrast Media | March 13, 2017
March 13, 2017 — The Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency recently...
Technical University of Munich, Munich Compact Light Source, MuCLS, angiography, contrast agents

(a) Photograph of the sample in waterbath. (b) Empty image of full MuCLS beam. (c) Quasi-mono-energetic angiography image of a porcine heart acquired at the MuCLS, with iodine-based contrast agent injected into the left coronary artery. Visible are the left anterior descending artery (LAD) and the left circumflex artery (LCX). Image courtesy of the authors.

News | Angiography | March 10, 2017
March 10, 2017 — The most prevalent method for obtaining images of clogged coronary vessels is coronary angiography....
Lantheus Medical Imaging, Definity, FDA approval, label update, echocardiography, cardiac shunt contraindication
Technology | Contrast Media | February 02, 2017
February 2, 2017 — Lantheus Medical Imaging Inc. announced U.S. Food and Drug Administration (FDA) approval of a label...
CT, computed tomography, IV contrast media, acute kidney injury risk, Annals of Emergency Medicine study

A new study in Annals of Emergency Medicine finds no association between intravenous contrast media used in computed tomography (CT) and kidney damage. Roughly 80 million doses of IV contrast media are given every year. Credit: American College of Emergency Physicians

News | Contrast Media | January 30, 2017
January 30, 2017 — Intravenous contrast media (typically iohexol or iodixanol) used in computed tomography (CT) does...
Videos | Magnetic Resonance Imaging (MRI) | December 19, 2016
Emanuel Kanal, M.D., director of MRI services and professor of radiology and neuroradiology at the University of...
GE Healthcare, Optison ultrasound contrast agent, FDA labeling change, cardiac shunts, intra-arterial injection
Technology | Contrast Media | October 04, 2016
October 4, 2016 — GE Healthcare announced that the U.S. Food and Drug Administration (FDA) has approved a label change...
Toshiba, Aplio 500 Platinum ultrasound, International Contrast Ultrasound Society, ICUS, live case, contrast-enhanced ultrasound
News | Ultrasound Imaging | September 07, 2016
September 7, 2016 — Toshiba America Medical Systems Inc. announced that its Aplio 500 Platinum ultrasound system will...
DyeVer, Osprey, Ospray, contrast reduction system
News | Cath Lab | August 05, 2016
August 5, 2016 — Osprey Medical Inc. said it received commitments from investors for approximately $28 million...
gadolinium, ACR Manual on Contrast Media, update, FDA safety concerns
News | Magnetic Resonance Imaging (MRI) | July 12, 2016
July 12, 2016 — The updated American College of Radiology (ACR) Manual on Contrast Media contains a statement...
Osprey Avert
News | Cath Lab | May 13, 2016
May 13, 2016 — In the largest study of its kind, a new device has been found to significantly reduce the volume of...
GlobalData, contrast media injectors market,
News | Contrast Media Injectors | May 03, 2016
May 3, 2016 — The global market for contrast media injectors is set to increase from $830 million in 2015 to almost $1....
MR angiography, MRA, Bayer, Gadavist, gadobutrol injection, FDA approval, supra-aortic arteries
Technology | Contrast Media | April 29, 2016
April 29, 2016 — Bayer announced that the U.S. Food and Drug Administration (FDA) has approved Gadavist (gadobutrol)...
Toshiba

Kidney ultrasound perfusion exam, courtesy of Toshiba.

Feature | Angiography | April 15, 2016
April 15, 2016 — Patients treated with CMX-2043 — an investigational drug that has previously shown some ability to...
News | Contrast Media | April 13, 2016
April 13, 2016 — The global market for contrast media is set to rise from just over $4.3 billion in 2015 to over $6...
Duke University study, molecular lightbulbs, MRI imaging agent

Duke scientists have discovered a new class of inexpensive and long-lived molecular tags that enhance MRI signals by 10,000-fold. To activate the tags, the researchers mix them with a newly developed catalyst (center) and a special form of hydrogen (gray), converting them into long-lived magnetic resonance 'lightbulbs' that might be used to track disease metabolism in real time. Image courtesy of Thomas Theis, Duke University.

News | Magnetic Resonance Imaging (MRI) | March 28, 2016
March 28, 2016 — Duke University researchers have taken a major step towards realizing a new form of magnetic resonance...